Mesenchymal Deletion of Histone Demethylase NO66 in Mice Promotes Bone Formation

Our previous studies indicated that the Jumonji C (JmjC)‐domain‐containing NO66 is a histone demethylase with specificity for methylated histone H3K4 and H3K36. NO66 binds to the transcription factor Osterix (Osx) and inhibits its transcriptional activity in promoter assays. However, the physiological role of NO66 in formation of mammalian bones is unknown. Here, using a genetically engineered mouse model, we show that during early skeletal development, Prx1‐Cre–dependent mesenchymal deletion of NO66 promotes osteogenesis and formation of both endochondral as well as intramembranous skeletal elements, leading to a larger skeleton and a high bone mass phenotype in adult mice. The excess bone formation in mice where NO66 was deleted in cells of mesenchymal origin is associated with an increase in the number of preosteoblasts and osteoblasts. Further analysis revealed that in the embryonic limbs and adult calvaria of mice with deletion of NO66 in cells of mesenchymal origin, expression of several genes including bone morphogenetic protein 2 (Bmp2), insulin‐like growth factor 1 (Igf1), and osteoclast inhibitor osteoprotegerin was increased, concurrent with an increase in expression of bone formation markers such as osterix (Osx), type I collagen, and bone sialoprotein (Bsp). Taken together, our results provide the first in vivo evidence that NO66 histone demethylase plays an important role in mammalian osteogenesis during early development as well as in adult bone homeostasis. We postulate that NO66 regulates bone formation, at least in part, via regulating the number of bone‐forming cells and expression of multiple genes that are critical for these processes. © 2015 American Society for Bone and Mineral Research.

[1]  Wenbin Liu,et al.  Identification and Characterization of MicroRNAs Controlled by the Osteoblast-Specific Transcription Factor Osterix , 2013, PloS one.

[2]  Xiaobing Shi,et al.  Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation , 2012, Nature Structural &Molecular Biology.

[3]  M. Dharsee,et al.  Proteomics analyses of activated human optic nerve head lamina cribrosa cells following biomechanical strain. , 2012, Investigative ophthalmology & visual science.

[4]  L. Deng,et al.  Effects of insulin and insulin‐like growth factor 1 on osteoblast proliferation and differentiation: differential signalling via Akt and ERK , 2012, Cell biochemistry and function.

[5]  Jennifer J Westendorf,et al.  Update on Wnt signaling in bone cell biology and bone disease. , 2012, Gene.

[6]  Jian Q. Feng,et al.  Multiple functions of Osterix are required for bone growth and homeostasis in postnatal mice , 2010, Proceedings of the National Academy of Sciences.

[7]  N. V. Kirienko,et al.  SLR‐2 and JMJC‐1 regulate an evolutionarily conserved stress‐response network , 2010, The EMBO journal.

[8]  H. Yasuda,et al.  Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase , 2009, The EMBO journal.

[9]  E. Canalis.  Growth factor control of bone mass , 2009, Journal of cellular biochemistry.

[10]  T. Day,et al.  Wnt and hedgehog signaling pathways in bone development. , 2008, The Journal of bone and joint surgery. American volume.

[11]  E. Kleinerman,et al.  The Osterix Transcription Factor Down-Regulates Interleukin-1α Expression in Mouse Osteosarcoma Cells , 2008, Molecular Cancer Research.

[12]  Yusuke Nakamura,et al.  Identification of Myc-associated protein with JmjC domain as a novel therapeutic target oncogene for lung cancer , 2007, Molecular Cancer Therapeutics.

[13]  Yang Shi,et al.  Dynamic regulation of histone lysine methylation by demethylases. , 2007, Molecular cell.

[14]  Yi Zhang,et al.  JmjC-domain-containing proteins and histone demethylation , 2006, Nature Reviews Genetics.

[15]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[16]  Ayse B. Celil,et al.  BMP-2 and Insulin-like Growth Factor-I Mediate Osterix (Osx) Expression in Human Mesenchymal Stem Cells via the MAPK and Protein Kinase D Signaling Pathways* , 2005, Journal of Biological Chemistry.

[17]  Ayse B. Celil,et al.  Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling , 2005, Journal of cellular biochemistry.

[18]  D. Ornitz,et al.  Sequential roles of Hedgehog and Wnt signaling in osteoblast development , 2004, Development.

[19]  Qin Chen,et al.  Inhibition of Lens Fiber Cell Morphogenesis by Expression of a Mutant SV40 Large T Antigen That Binds CREB-binding Protein/p300 but Not pRb* , 2004, Journal of Biological Chemistry.

[20]  M. Schnölzer,et al.  NO66, a highly conserved dual location protein in the nucleolus and in a special type of synchronously replicating chromatin. , 2004, Molecular biology of the cell.

[21]  K. Nakashima,et al.  Transcriptional mechanisms in osteoblast differentiation and bone formation. , 2003, Trends in genetics : TIG.

[22]  C. Tabin,et al.  Expression of Cre recombinase in the developing mouse limb bud driven by a Prxl enhancer , 2002, Genesis.

[23]  T. Jenuwein,et al.  The many faces of histone lysine methylation. , 2002, Current opinion in cell biology.

[24]  J. Deng,et al.  The Novel Zinc Finger-Containing Transcription Factor Osterix Is Required for Osteoblast Differentiation and Bone Formation , 2002, Cell.

[25]  S. Mundlos,et al.  Cbfa1, a Candidate Gene for Cleidocranial Dysplasia Syndrome, Is Essential for Osteoblast Differentiation and Bone Development , 1997, Cell.

[26]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[27]  Makoto Sato,et al.  Targeted Disruption of Cbfa1 Results in a Complete Lack of Bone Formation owing to Maturational Arrest of Osteoblasts , 1997, Cell.

[28]  N. Udagawa,et al.  Action of RANKL and OPG for osteoclastogenesis. , 2009, Critical reviews in eukaryotic gene expression.